BeyondSpring (BYSI) Invested Capital (2015 - 2021)

BeyondSpring (BYSI) posted Invested Capital of $1.6 million for Q4 2021, up 1.1% sequentially from $1.6 million in Q3 2021.

BeyondSpring (BYSI) Invested Capital (2015 - 2021) Analysis & Trends

BeyondSpring has reported Invested Capital for 6 years, with the latest figure at $1.6 million in Q4 2021.

Quarterly Invested Capital changed N/A year-over-year to $1.6 million in Q4 2021, while the trailing twelve-month figure through Jun 2023 was $1.6 million (down 70.42% YoY) and the FY2021 annual result came in at $1.6 million, changed N/A from the prior year.
Invested Capital grew to $1.6 million in Q4 2021 per BYSI's latest filing, from $1.6 million in the prior quarter.
Over five years, Invested Capital peaked at $2.2 million in Q2 2021 and troughed at $2000.0 in Q2 2017.
A 4-year average of $724916.7 and a median of $205500.0 in 2019 frame the typical range for Invested Capital.
The sharpest annual moves came in 2020 and 2021: Invested Capital tumbled 95.56% in 2020, then soared 3533.33% in 2021.
Over 4 years, Invested Capital stood at $2000.0 in 2017, then jumped by 1350.0% to $29000.0 in 2019, then jumped by 110.34% to $61000.0 in 2020, then soared by 2472.13% to $1.6 million in 2021.
According to Business Quant data, Invested Capital over the past three periods registered $1.6 million, $1.6 million, and $2.2 million for Q4 2021, Q3 2021, and Q2 2021 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	37.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	190.90 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	1.45 Bn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	380.00 Mn
10	BeyondSpring	29.85 Mn	29.85 Mn	-	-

Download Data